Dividend compounder review

BNTX

BioNTech SE · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score31.05/100
Confidence88.00/100
DecisionReject
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 2.5 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 8.5 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 13.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 7.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 0.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years1
Dividend Yield2.33%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$-1.1B
Free Cash Flow$-293.0M
FCF Covers DividendNo
Debt / Equity1.62
P/E-
Revenue Growth 5Y41.7%
Net Margin-44.6%
ROE-6.7%
Price vs Trend-8.1%
3Y Return-15.5%
5Y Return-60.1%
CurrencyUSD
Warnings

Review flags

Price currency USD differs from financial currency EUR.
Dividend history is short: 1 completed years.
Free cash flow is negative.
Free cash flow does not cover dividends paid.
Dividend diary

Activity record

BNTX dividend review warning Warning · Warning

Free cash flow does not cover dividends paid.

BNTX dividend payment 2.111 USD Dividend Payment · Info

Recorded dividend payment for BioNTech SE.